🚀 VC round data is live in beta, check it out!
Darya-Varia Laboratoria Valuation Multiples
Discover revenue and EBITDA valuation multiples for Darya-Varia Laboratoria and similar public comparables like SynAct Pharma, Gossamer Bio, Pyxis Oncology, Zomedica and more.
Darya-Varia Laboratoria Overview
About Darya-Varia Laboratoria
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, medical and dental equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics; wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory equipment, cosmetic; wholesale trade in pharmaceuticals; laboratory testing services, health support service activities, research and development, periodic inspection services, and many more activities.
Founded
1976
HQ
Employees
1.7K
Website
Financials (FY)
EV
$85M
Darya-Varia Laboratoria Financials
Darya-Varia Laboratoria reported last fiscal year revenue of $130M and EBITDA of $15M.
In the same fiscal year, Darya-Varia Laboratoria generated $71M in gross profit, $15M in EBITDA, and $10M in net income.
Darya-Varia Laboratoria P&L
In the most recent fiscal year, Darya-Varia Laboratoria reported revenue of $130M and EBITDA of $15M.
Darya-Varia Laboratoria expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $130M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $71M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 54% | XXX | XXX | XXX |
| EBITDA | — | XXX | $15M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 12% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 9% | XXX | XXX | XXX |
| Net Profit | — | XXX | $10M | XXX | XXX | XXX |
| Net Margin | — | XXX | 7% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Darya-Varia Laboratoria Stock Performance
Darya-Varia Laboratoria has current market cap of $105M, and enterprise value of $85M.
Market Cap Evolution
Darya-Varia Laboratoria's stock price is $0.09.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $85M | $105M | 0.0% | XXX | XXX | XXX | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDarya-Varia Laboratoria Valuation Multiples
Darya-Varia Laboratoria trades at 0.7x EV/Revenue multiple, and 5.6x EV/EBITDA.
Darya-Varia Laboratoria Financial Valuation Multiples
As of April 19, 2026, Darya-Varia Laboratoria has market cap of $105M and EV of $85M.
Equity research analysts estimate Darya-Varia Laboratoria's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Darya-Varia Laboratoria has a P/E ratio of 11.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $105M | XXX | $105M | XXX | XXX | XXX |
| EV (current) | $85M | XXX | $85M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 5.6x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 7.1x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.2x | XXX | XXX | XXX |
| P/E | — | XXX | 11.0x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 15.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Darya-Varia Laboratoria Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Darya-Varia Laboratoria Margins & Growth Rates
Darya-Varia Laboratoria's revenue in the last fiscal year grew by 7%.
Darya-Varia Laboratoria's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Darya-Varia Laboratoria Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 6% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 22% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 45% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Darya-Varia Laboratoria Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Darya-Varia Laboratoria | XXX | XXX | XXX | XXX | XXX | XXX |
| SynAct Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Gossamer Bio | XXX | XXX | XXX | XXX | XXX | XXX |
| Pyxis Oncology | XXX | XXX | XXX | XXX | XXX | XXX |
| Zomedica | XXX | XXX | XXX | XXX | XXX | XXX |
| Cognition Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Darya-Varia Laboratoria M&A Activity
Darya-Varia Laboratoria acquired XXX companies to date.
Last acquisition by Darya-Varia Laboratoria was on XXXXXXXX, XXXXX. Darya-Varia Laboratoria acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Darya-Varia Laboratoria
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDarya-Varia Laboratoria Investment Activity
Darya-Varia Laboratoria invested in XXX companies to date.
Darya-Varia Laboratoria made its latest investment on XXXXXXXX, XXXXX. Darya-Varia Laboratoria invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Darya-Varia Laboratoria
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Darya-Varia Laboratoria
| When was Darya-Varia Laboratoria founded? | Darya-Varia Laboratoria was founded in 1976. |
| Where is Darya-Varia Laboratoria headquartered? | Darya-Varia Laboratoria is headquartered in Indonesia. |
| How many employees does Darya-Varia Laboratoria have? | As of today, Darya-Varia Laboratoria has over 1K employees. |
| Is Darya-Varia Laboratoria publicly listed? | Yes, Darya-Varia Laboratoria is a public company listed on Indonesia Stock Exchange. |
| What is the stock symbol of Darya-Varia Laboratoria? | Darya-Varia Laboratoria trades under DVLA ticker. |
| When did Darya-Varia Laboratoria go public? | Darya-Varia Laboratoria went public in 1994. |
| Who are competitors of Darya-Varia Laboratoria? | Darya-Varia Laboratoria main competitors are SynAct Pharma, Gossamer Bio, Pyxis Oncology, Zomedica. |
| What is the current market cap of Darya-Varia Laboratoria? | Darya-Varia Laboratoria's current market cap is $105M. |
| What is the current revenue of Darya-Varia Laboratoria? | Darya-Varia Laboratoria's last fiscal year revenue is $130M. |
| What is the current EV/Revenue multiple of Darya-Varia Laboratoria? | Current revenue multiple of Darya-Varia Laboratoria is 0.7x. |
| Is Darya-Varia Laboratoria profitable? | No, Darya-Varia Laboratoria is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.